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Abstract
Background: Our objective was to evaluate the effect of ovarian endometrioma on ovar-
ian stimulation outcomes in in vitro fertilization cycles (IVF).     
Materials and Methods: In this prospective cohort study, we followed 103 patients who 
underwent intra-cytoplasmic sperm injection (ICSI) procedures over a 24-months period. 
The study group consisted of 47 infertile women with either unilateral or bilateral ovarian 
endometrial cysts of less than 3 cm. The control group consisting of 57 patients with mild 
male factor infertility was candidate for ICSI treatment during the same time period as 
the study groups. Both groups were compared for number of oocytes retrieved, grades of 
oocytes, as well as embryo quantity and quality.  
Results: Our results showed similar follicle numbers, good embryo grades (A or B) 
and pregnancy rates in the compared groups. However, patients with endometrioma had 
higher gonadotropin consumption than the control group. The mean number of retrieved 
oocytes in patients with endometrioma was significantly lower than control group (6.6 
± 3.74 vs. 10.4 ± 5.25) (p<0.001). In addition, patients with endometrioma had signifi-
cantly lower numbers of metaphase II (MII) oocytes (5 ± 3.21) than controls (8.2 ± 5.4) 
(p<0.001). In patients with unilateral endometrioma, there were no significant differences 
in main outcome measures between normal and involved ovaries in the patients with 
endometrioma.   
Conclusion: Patients with ovarian endometrioma had poor outcome. They showed poor ovar-
ian response with lower total numbers of retrieved oocytes and lower MII oocytes during the 
stimulation phase; however, it does not affect the total number of embryos transferred per pa-
tient, quality of embryos, and pregnancy rate per patient.
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Introduction
At present, approximately 20-35% of all pa-
tients undergoing in vitro fertilization (IVF) are 
diagnosed with endometriosis (1, 2) among whom 
about 30-40% suffer from ovarian endometrioma 
(3, 4). The impact of ovarian endometrioma on as-
sisted reproductive technologies (ART) results is 
a controversial issue. A previous meta-analysis 
(5) has shown reduced pregnancy rates in women 
with ovarian endometrioma who underwent IVF 
treatments when compared to patients with other 
infertility causes. However, other studies have not 
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confirmed this finding (6-8). In addition, some 
studies have shown that ovarian endometrioma 
could adversely affect the number of oocytes re-
trieved (7, 9), oocyte quality, fertilization rate 
(5, 10), embryo quality and implantation rate (9, 
11, 12). Kumbak et al. (13) have also reported 
poor embryo quality in patients with endometri-
osis; yet, there have been no effect on pregnancy 
rate. Other studies also found no adverse effect 
of ovarian endometrioma on pregnancy success 
rates (14-16).
Due to these conflicting results, the optimum 
management of ovarian endometrioma in IVF/
intra cytoplasmic sperm injection (ICSI) cycles is 
not clear (14, 17). Some authors believe that ovar-
ian endometriomas should be removed before the 
IVF cycle (18); however, others have shown that 
excision of an ovarian endometrioma before an 
IVF cycle is likely to lead poor responses to ovar-
ian stimulation and to impact fertility outcomes 
(19, 20). 
The purpose of the present study was to evaluate 
the effect of ovarian endometriomas on ovarian re-
sponse and IVF/ ICSI outcomes when compared to 
patients with mild male factor infertility.
Materials and Methods
This cohort study was performed at Royan Insti-
tute for Reproductive Biomedicine (Tehran, Iran) 
over a 24-months period between March 2005 and 
December 2007. We recruited a total of 104 wom-
en who were candidates for IVF/ICSI and fresh 
embryo transfers.
The study group consisted of 47 infertile women 
with either unilateral or bilateral ovarian endome-
trial cysts of less than 3 cm, based upon transvagi-
nal sonographic diagnosis with diffuse low-level 
echoes without neoplastic or acute hemorrhage 
features. Patients had no histories of any ovarian 
surgeries. All ultrasound tests were performed by 
two expert technicians using an EUB 6000 (HI-
TACHI, Japan) equipped with a 6 MHZ curvilin-
ear color doppler probe. Technicians performed 
trans-vaginal ultrasounds between days 1 and 8 
of the cycle, before starting ovarian stimulation. 
The location and dimension of the endometriomas 
were recorded at this time.
Patients with endometriomas larger than 3 cm 
underwent endometriotic cystectomy, via laparo-
scopic surgery. These patients were not included 
at the study. There was no patient with cystecto-
mies, defined as a laparoscopic surgery applied for 
women with small ovarian endometriomas.
The control group consisting of 57 patients with 
mild male factor infertility was candidate for ICSI 
treatment during the same time period as the study 
groups. Mild male factor infertility was defined as 
the presence of at least 1 million motile sperm af-
ter processing.
All patients in both groups had indications for 
IVF/ICSI treatments, without any previous at-
tempts.
Exclusion criteria for both groups were as fol-
lows: i. previous history of any systematic disease 
or malignancy, ii. basal follicle-stimulating hor-
mone (FSH) more than 15 mIU/ml, iii. history of 
three or more unsuccessful IVF attempts, and iv. 
ovarian endometrioma less than 3 cm.
The study was approved by the Ethics Commit-
tee of Royan Institute for Reproductive Biomedi-
cine. A written informed consent was obtained 
from all individuals before participation.
Stimulation protocol for all patients was ac-
cording to the standard long protocol. All patients 
underwent oral contraceptive suppression start-
ing from the 2nd or 3rd day of the menstrual cycle. 
Gonadotropin-releasing hormone agonist (GnRH 
agonist) suppression with Busereline (500 µg, 
Suprefact; Aventis Pharma Deutshlan, Frankfurt, 
Germany) was performed via subcutaneous injec-
tion starting on the 21st day of the menstrual cycle. 
We began gonadotropin stimulation 14 days after 
subcutaneous GnRH agonist injection with daily 
dose of 150 IU of recombinant FSH (Gonal F; Se-
rono, Geneva, Switzerland). The dose and duration 
of FSH treatment were adjusted by monitoring fol-
licular development using ultrasound and estradiol 
levels. In both groups, gonadotropin stimulation 
continued until 2-3 follicles with a mean diameter 
of ≥17 mm were achieved. Then, 10000 IU of hu-
man chorionic gonadotropin (hCG; Choriomon; 
IBSA, Lugano, Switzerland) was administered, 
while oocyte retrieval was performed 34-36 hours 
later by a skilled gynecologist. Only normal folli-
cles were punctured at the time of oocyte retrieval. 
During the procedure, every effort was made to 
avoid puncturing the endometrioma. If endometri-
omas were accidentally punctured, the procedure 
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was interrupted and resumed after the needled was 
changed.
Metaphase II (MII) oocytes were injected us-
ing ICSI procedure. Normal fertilization was con-
firmed when two distinct pronuclei were present 
within 16-18 hours following oocyte injection.
ICSI procedure 
In our ICSI cycles, cumulus-enclosed oocytes 
were treated with 0.1% hyaluronidase, and the 
cumulus cells were mechanically removed by 
pipetting. Oocyte maturation stage and morphol-
ogy were assessed under an inverted microscope 
(Olympus, Tokyo, Japan) at ×400 magnification. 
Oocytes were classified as MII oocyte (mature oo-
cyte), metaphase I oocyte, or prophase I oocyte. 
Good quality cleaved embryos (21) were trans-
ferred 2-3 days after oocyte retrieval.
Progesterone supplementation (400 mg twice a 
day; Aburaihan Co., Tehran, Iran) was provided 
at time of oocyte retrieval until the day of β-hCG 
assay. After obtaining a positive pregnancy test re-
sult, it was continued until the 10th week of gesta-
tion.
The initial dose, total dose and days of gonado-
tropin, endometrium thickness, and concentration 
of estradiol (E
2
) on the days of hCG injection were 
recorded. Numbers of retrieved eggs, rate of cleav-
age, numbers of embryos grades A and B obtained, 
scores of the transferred embryos, as well as rates 
of clinical pregnancy and implantation were cal-
culated.
Outcome 
Primary endpoints were ovarian response and 
oocyte quality and quantity. The quality of em-
bryos, biochemical, clinical pregnancy and im-
plantation rates were other outcomes of interest. 
We defined the fertilization rate as the ratio of the 
number of embryos formed relative to the num-
ber of MII oocytes injected. The maturation rate 
was the ratio of MII oocytes to the number of total 
retrieved oocytes. Clinical pregnancy was a posi-
tive pregnancy test result followed by the presence 
of a gestational sac on trans-vaginal ultrasound, 4 
weeks after transfer. The pregnancy rate in the pre-
sent study was calculated by dividing the number 
of clinical pregnancies detected by the number of 
patients (clinical pregnancy per patient). The im-
plantation rate was the number of gestational sacs 
visualized by trans-vaginal pelvic ultrasound per 
embryos transferred. In addition, we compared the 
normal and involved ovaries in patients with uni-
lateral endometrioma.
Statistical analysis  
Analysis was performed using the SPSS (ver-
sion 13.0; SPSS Inc., Chicago, IL, USA) statistical 
software. Between-group differences of normally 
distributed continuous variables were assessed 
by student’s t test, whereas the Mann-Whitney U 
test was used for the abnormal distributed data. 
Significant differences were evaluated by the chi-
square test to compare non-continuous variables. 
In inter-group comparison, the paired t test analy-
sis and Wilcoxon Signed Ranks test were applied 
for patients with unilateral endometrioma and for 
nonparametric cases, respectively. Data were ex-
pressed as mean ± standard deviation (SD). Sta-
tistical significance was considered when p<0.05. 
Results
The baseline characteristics including age, dura-
tion of infertility, and basic concentrations of E2 
and FSH level were similar between two groups 
(Table 1).
The mean number of retrieved oocytes in patients 
with endometrioma and in control group were 6.6 
± 3.74 vs. 10.4 ± 5.25, respectively (p<0.001). As 
seen in table 2, the numbers of MII oocytes were 
significantly lower in patients with endometrioma 
(5 ± 3.21) as compared to the control group (8.2 
± 5.4).
The thickness of the endometrium, follicle num-
bers and good quality embryos (grades A or B) 
were also comparable between the two groups 
(p>0.05). Both groups had similar implantation 
and pregnancy rates (Table 2). However, patients 
with endometrioma had higher gonadotropin con-
sumption as compared with the control group. We 
had no severe ovarian hyperstimulation syndrome 
(OHSS) in both groups.
In patients with unilateral endometrioma, we 
compared outcomes between the affected ovary 
and healthy contra lateral ovary. There were no 
significant differences in terms of main outcome 
measures between the normal and involved ova-
ries (Table 3).
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Table 1: Comparison of the baseline characteristics between patients with endometrioma and control groups
P value Control group (n= 57)Patients with endometrioma (n= 47)
0.124 30.6 ± 4.7131.9 ± 4.01Age (Y) 
0.2817.2 ± 5.188.3 ± 5.06Duration of infertility(Y) 
0.3626.2 ± 2.106.7 ± 2.76Basal FSH level (IU/Lit)
0.1595.5 ± 3.276.5 ± 3.87Basal LH level (IU/Lit) 
0.906 38 (1.4- 4800) 45.0 (2.9-1100.0)Basal estradiol level (Pg/ml) * 
Data are expressed as mean ± SD, otherwise it is reported.
*; Median(Min-Max) and Mann-Whitney test is used.
Table 2: Comparison of ICSI cycles outcomes between the patients with endometrioma and control groups
P valueControl group (n=57)Patients with endometrioma (n=47)
0.00124 ± 9.3531.8 ± 13.03Total number of gonadotropin ampoules
0.8029.4 ± 1.89.3 ± 2.06Endometrium thickness (mm)
0.73612.7± 10.613.4 ± 11.4 Follicle number
<0.00110.4 ± 5.26.6 ± 3.7Total number of oocytes retrieved
<0.0018.4 ± 5.15.04 ± 3.2MII oocytes retrieved
0.0402.7 ± 0.93.2 ± 0.9Total number of embryos transferred
0.0844.9 ± 2.3 3.8 ± 2.5Total formed embryos
0.5882.6 ± 3.12.9 ± 2.3Good quality formed embryos
0.0402.7 ± 0.943.2 ± 0.9Total transferred embryo
<0.0011.7 ± 1.32.8 ± 1.2Good quality transferred embryos
<0.001283/480 (59.0)173/237 (73.0)Fertilization rate (%)
 OR=1.882 (1.340-2.643)*
0.105480/594 (80.8)237/311 (76.2)Maturation rate (%)
 OR=0.761 (0.546-1.060)*
0.2762(3.5)4 (8.5)Cancellation rate (%)
 OR=2.558 (0.447-14.628)*
0.44317/143 (11.9)20/133 (15.0)Implantation rate (%)
OR=1.312 (0.655-2.628)*
0.25314 (26.4)15 (37.5)Clinical pregnancy rate (%)
OR=0.6729 (0.284-1.59)*
0.526 3 (18.8)4 (28.6)                  Multiple pregnancy rate (%)
OR=1.73 (0.31, 9.57)*
 Data are expressed as mean ± SD. OR; Odds ratio and  *; 95% Confidence interval for odds ratio.
33
Endometrioma and IVF Cycles
Table 3: Comparison of the clinical outcomes between the normal and involved ovaries in the patients with unilateral 
endometrioma
P value (% 95 CI)Normal ovary (n= 37)Ovary with endometrioma (n= 37)
0.532 (-0.957, 1.822)6.6 ± 5.87.02 ± 6.9Follicle number 
0.368 (-1.744, 0.663)3.4 ± 2.72.8 ± 2.4Total number of oocytes retrieved





0.226 (-1.358, 0.331)2.05 ± 1.841.5 ± 1.54Total formed embryos
0.162 (-0.719, 0.125)0.8 ± 1.20.5 ± 0.73Total formed embryos grade A 
0.094 (-0.64, 0.053)0.8 ± 0.80.5 ± 0.76Total formed embryos grade B
0.833 (-0.569, 0.461)0.5 ± 1.160.4 ± 0.86Total formed embryos grade C 
Data are expressed as mean ± SD, otherwise it is mentioned. 
*Odds ratio and *; 95% confidence interval for odds ratio.
Discussion
In the present study, the number of retrieved oo-
cytes and MII oocytes were significantly lower in 
endometrioma patients than the controls; however, 
the number of good quality embryos (per MII in-
jected oocyte) was comparable in both groups.
These results were consistent with previous inves-
tigations that found a lower ovarian response to gon-
adotropin stimulation in patients with endometrioma 
(13, 22). Al-Azemi et al. (23) have reported that ovar-
ian endometrioma led to a decreased response to gon-
adotropins, as reflected by the smaller number of  re-
trieved oocytes, which was also shown in our study.
Pellicer et al. (24) have demonstrated that endo-
metriosis caused poor quality oocytes and embry-
os with decreased ability for implantation. Differ-
ent mechanisms such as changes in autoimmune 
factors, cytokines or production of growth factors, 
increased rate of granulosa cell apoptosis, and de-
creased steroid levels were considered as negative 
factors for follicular growth and oocyte maturity in 
these patients (25, 26).
Although some studies have reported poor 
IVF-embryo transfer (ET) outcomes with endome-
triosis  (9, 11, 12), we could not find any negative 
impact of ovarian endometrioma on clinical pregnan-
cy and implantation rates. Some scholars have also 
shown that the existence of endometrioma did not in-
fluence embryo implantation, and have proposed that 
the detrimental effects were limited to the fertilization 
phase (27).
In patients with unilateral endometrioma, the pres-
ence of endometrioma at the time of aspiration did 
not compromise our ICSI outcomes. This result was 
in accordance with the study of Almog et al. (28) in 
which they found a similar number of antral follicles 
and oocytes retrieved from the affected and healthy 
contra lateral ovaries. It seems that in women with 
unilateral disease, the contra lateral intact ovary com-
pensated for ovarian function and fertility potential 
(14). In the present study, we did not include patients 
who had surgery for their endometriosis. Additional 
studies are required to evaluate the effect of surgery.
Conclusion
Despite the lower response to gonadotropins 
in endometrioma patients, the rates of pregnan-
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cy and implantation rates, embryo quality, total 
number of embryos transferred per patient and 
fertilization of MII oocytes were not affected 
by the presence of the endometrioma. It seems 
that endometrial receptivity in two groups was 
similar. However, in consideration of the higher 
cancelling rate, the prognosis for patients with 
endometrioma was worse than in patients with 
male associated infertility. 
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